Children's Hospital Boston
Boston, Massachusetts, 02115, United States
NCT Number: NCT01040988
The introduction of pacemakers and implantable cardioverter-defibrillators (ICDs) has substantially changed the medical and surgical management of patients with cardiac rhythm disease. In the case of patients with ICDs, these devices are programmed to deliver a strong electrical shocks. In adults, multiple studies have suggested that patients at risk of receiving shocks from their device have an increased prevalence of anxiety and depression. Very few studies have looked at this question in children. We propose to evaluate a cohort of patients age 6 to 20 with ICDs, compared to a cohort of patients with pacemakers, assessing each group for the presence of depressive and anxiety disorders, including post-traumatic stress disorder (PTSD).
Looking for future studies?
Notify Me6 year–20 year
All sexes
Observational
Boston, Massachusetts, 02115, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: One-time measure at enrollment
Time frame: One-time at enrollment
Time frame: One-time at enrollment
Time frame: One-time at enrollement
Time frame: One-time at enrollment
Boston Children's Hospital
Other
The ICD/Device Expectations, Adaptations, and Successes (IDEAS) Study: the Relationship Between Implantable Cardioverter-defibrillators, Pacemakers and Psychiatric Symptoms in a Pediatric Population
Acronym: IDEAS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05344092
Anxiety, Anxiety Disorders
Bedford, Massachusetts, United States
View Trial DetailsNCT04163341
Acquired Immunodeficiency Syndrome, Anxiety
Birmingham, Alabama, United States
View Trial DetailsNCT03458039
Anxiety, Anxiety Disorders
Lusaka, Zambia
View Trial DetailsNCT05092529
Anxiety, Anxiety Disorders
Truro, Cornwall, United Kingdom
View Trial Details